<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">862910</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2022.862910</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Intron-Encoded Domain of Herstatin, An Autoinhibitor of Human Epidermal Growth Factor Receptors, Is Intrinsically Disordered</article-title>
<alt-title alt-title-type="left-running-head">Tashiro et al.</alt-title>
<alt-title alt-title-type="right-running-head">Herstatin is Intrinsically Disordered</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tashiro</surname>
<given-names>Daisuke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1709979/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Suetaka</surname>
<given-names>Shunji</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1762964/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sato</surname>
<given-names>Nao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1762965/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ooka</surname>
<given-names>Koji</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1763298/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kunihara</surname>
<given-names>Tomoko</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kudo</surname>
<given-names>Hisashi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1763030/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Inatomi</surname>
<given-names>Junichi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hayashi</surname>
<given-names>Yuuki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1762994/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Arai</surname>
<given-names>Munehito</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/445749/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Life Sciences</institution>, <institution>Graduate School of Arts and Sciences</institution>, <institution>The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Physics</institution>, <institution>Graduate School of Science</institution>, <institution>The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/32277/overview">Vladimir N. Uversky</ext-link>, University of South Florida, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/138879/overview">Daniel E. Otzen</ext-link>, Aarhus University, Denmark</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1592590/overview">Bogdan Melnik</ext-link>, Institute of Protein Research (RAS), Russia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/675924/overview">Arne Raasakka</ext-link>, University of Bergen, Norway</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Munehito Arai, <email>arai@bio.c.u-tokyo.ac.jp</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Protein Folding, Misfolding and Degradation, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>862910</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Tashiro, Suetaka, Sato, Ooka, Kunihara, Kudo, Inatomi, Hayashi and Arai.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tashiro, Suetaka, Sato, Ooka, Kunihara, Kudo, Inatomi, Hayashi and Arai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Human epidermal growth factor receptors (HER/ERBB) form dimers that promote cell proliferation, migration, and differentiation, but overexpression of HER proteins results in cancer. Consequently, inhibitors of HER dimerization may function as effective antitumor drugs. An alternatively spliced variant of HER2, called herstatin, is an autoinhibitor of HER proteins, and the intron 8-encoded 79-residue domain of herstatin, called Int8, binds HER family receptors even in isolation. However, the structure of Int8 remains poorly understood. Here, we revealed by circular dichroism, NMR, small-angle X-ray scattering, and structure prediction that isolated Int8 is largely disordered but has a residual helical structure. The radius of gyration of Int8 was almost the same as that of fully unfolded states, although the conformational ensemble of Int8 was less flexible than random coils. These results demonstrate that Int8 is intrinsically disordered. Thus, Int8 is an interesting example of an intrinsically disordered region with tumor-suppressive activity encoded by an intron. Furthermore, we show that the R371I mutant of Int8, which is defective in binding to HER2, is prone to aggregation, providing a rationale for the loss of function.</p>
</abstract>
<kwd-group>
<kwd>human epidermal growth factor receptor</kwd>
<kwd>herstatin</kwd>
<kwd>intron-encoded protein</kwd>
<kwd>intrinsically disordered protein</kwd>
<kwd>pre-molten globule state</kwd>
<kwd>small-angle X-ray scattering</kwd>
</kwd-group>
<contract-num rid="cn001">JP16H02217 JP19H02521 JP21K18841</contract-num>
<contract-sponsor id="cn001">Japan Society for the Promotion of Science<named-content content-type="fundref-id">10.13039/501100001691</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Human epidermal growth factor receptors (HER/ERBB) are receptor tyrosine kinases that play crucial roles in the regulation of cell proliferation, migration, and differentiation (<xref ref-type="bibr" rid="B13">Citri and Yarden, 2006</xref>). The HER family comprises four members, namely HER1 (EGFR), HER2 (NEU), HER3, and HER4 with differential tissue expression patterns. All four members of the family share a common three-dimensional structure that comprises an extracellular domain (ECD), a transmembrane domain, and an intracellular kinase domain (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="bibr" rid="B73">Yarden and Pines, 2012</xref>). Homo- or hetero-dimerization of the ECD induces autophosphorylation of the intracellular kinase domain, which in turn results in activation of downstream signaling molecules (<xref ref-type="bibr" rid="B50">Normanno et al., 2003</xref>; <xref ref-type="bibr" rid="B47">Mujoo et al., 2014</xref>). Genetic variants that disrupt the function of these proteins or lead to their overexpression have been associated with multiple cancers (<xref ref-type="bibr" rid="B25">Howe and Brown, 2011</xref>). For instance, HER1 variants are associated with lung, breast, and prostate cancers (<xref ref-type="bibr" rid="B50">Normanno et al., 2003</xref>), whereas HER2 variants have been found in approximately 30% of all breast cancers (<xref ref-type="bibr" rid="B62">Tai et al., 2010</xref>). Thus, the interruption of HER dimerization by specific inhibitors is an effective strategy to halt the growth of cancer cells. Several antibody therapeutics that function <italic>via</italic> this mechanism have been developed, including trastuzumab (herceptin) and pertuzumab that target HER2, and cetuximab that targets HER1.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Structures of HER2 and herstatin. <bold>(A)</bold> Structure of HER2. The extracellular domain is composed of four subdomains, ECD I, ECD II, ECD III, and ECD IV. Seven glycosylation sites are shown by asterisks [N68, N124, N187, N259, N530, N571, and N629 according to the UniProt database (Accession number P04626) (<xref ref-type="bibr" rid="B66">UniProt Consortium, 2021</xref>)]. <bold>(B)</bold> Structure of herstatin. ECD I and ECD II are identical to those in HER2. An intron-8 encoded 79-residue domain, named Int8 (or ECD IIIa), is retained at the C-terminal region of herstatin. Four glycosylation sites identical to those in HER2 are shown by asterisks. Note that Int8 does not have a glycosylation site.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g001.tif"/>
</fig>
<p>Herstatin (dimercept) is an alternatively spliced variant of HER2 that retains intron 8 and is secreted by human cells (<xref ref-type="bibr" rid="B15">Doherty et al., 1999</xref>; <xref ref-type="bibr" rid="B60">Stix, 2006</xref>; <xref ref-type="bibr" rid="B58">Silipo et al., 2017</xref>; <xref ref-type="bibr" rid="B22">Hart et al., 2020</xref>). It lacks the intracellular kinase and transmembrane domains, but retains a part of the extracellular domain that binds to the ECDs of intact HER proteins. This results in the suppression of HER autophosphorylation and consequently arrests downstream signal transduction (<xref ref-type="bibr" rid="B15">Doherty et al., 1999</xref>; <xref ref-type="bibr" rid="B9">Camenisch et al., 2002</xref>; <xref ref-type="bibr" rid="B34">Justman and Clinton, 2002</xref>; <xref ref-type="bibr" rid="B30">Jhabvala-Romero et al., 2003</xref>; <xref ref-type="bibr" rid="B27">Hu et al., 2006</xref>; <xref ref-type="bibr" rid="B19">Gompels et al., 2011</xref>). Thus, herstatin can autoinhibit the function of HER proteins by binding them and interfering with their dimer formation (<xref ref-type="bibr" rid="B15">Doherty et al., 1999</xref>; <xref ref-type="bibr" rid="B5">Azios et al., 2001</xref>; <xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>). Furthermore, herstatin binds intracellular HER2 and possibly prevents its translocation from the endoplasmic reticulum to the cell surface (<xref ref-type="bibr" rid="B27">Hu et al., 2006</xref>). Given that herstatin is expressed in non-cancerous breast tissue (<xref ref-type="bibr" rid="B38">Koletsa et al., 2008</xref>), but is absent in about 75% of breast carcinomas, it may function as a tumor-suppressor. Consequently, its role as a growth regulatory factor during normal development can be possibly exploited in the development of antitumor therapies (<xref ref-type="bibr" rid="B59">Staverosky et al., 2005</xref>; <xref ref-type="bibr" rid="B60">Stix, 2006</xref>; <xref ref-type="bibr" rid="B38">Koletsa et al., 2008</xref>; <xref ref-type="bibr" rid="B29">Jackson et al., 2013</xref>).</p>
<p>Herstatin is a 68-kDa soluble protein, comprising two of the four subdomains of the ECD of HER2 (ECD I and ECD II, respectively; residues 1&#x2013;340), and a separate domain encoded by intron 8, referred to as Int8 (or ECD IIIa; residues 341&#x2013;419) (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The 79-residue Int8 domain binds with high affinity to HER1, HER2, HER4, and the insulin-like growth factor 1 receptor (<xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>; <xref ref-type="bibr" rid="B43">Lv et al., 2012</xref>). Even short peptides derived from the Int8 domain are known to bind HER2 (<xref ref-type="bibr" rid="B10">Cha et al., 2017</xref>). Interestingly, the Int8 domain inhibited the growth of HER2-overexpressing cells, suggesting the tumor-suppressing activity of Int8 (<xref ref-type="bibr" rid="B43">Lv et al., 2012</xref>).</p>
<p>Previous studies show that the isolated Int8 domain has a high affinity for HER proteins. This is evident from the fact that whereas a dissociation constant, <italic>K</italic>
<sub>d</sub>, was 14&#xa0;nM for the binding between the full-length herstatin and HER2 (<xref ref-type="bibr" rid="B15">Doherty et al., 1999</xref>), the <italic>K</italic>
<sub>d</sub> for Int8 binding to HER1 and HER2 was 78 &#xb1; 10&#xa0;nM and 50 &#xb1; 6&#xa0;nM, respectively, although Int8 does not have the dimerization arm, which is located in the ECD II (<xref ref-type="bibr" rid="B15">Doherty et al., 1999</xref>; <xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>). In accordance with this, Hu et al. demonstrated that deletion of the Int8 domain from herstatin considerably reduced the affinity with HER2 <italic>in vivo</italic>, suggesting that the Int8 domain plays a predominant role in the binding of herstatin to HER2 (<xref ref-type="bibr" rid="B26">Hu et al., 2005</xref>). Moreover, Shamieh et al. reported loss of interaction between the isolated Int8 domain and HER2 as a consequence of the R371I mutation in Int8 (residue number corresponds to full-length herstatin) (<xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>). However, while the role of the Int8 domain in HER binding is well established, its structure remains poorly understood.</p>
<p>Here, we characterized the structure of the isolated Int8 domain using circular dichroism (CD), nuclear magnetic resonance (NMR), and small-angle X-ray scattering (SAXS). Our results demonstrate that Int8 is intrinsically disordered with a residual helical structure. The structure prediction and modeling were consistent with experimental results. Furthermore, we show that the R371I mutant, which has a lower affinity for HER2, is prone to aggregation. Therefore, Int8 presents an interesting case, where an intrinsically disordered region (IDR) encoded by an intron possesses tumor-suppressive activity.</p>
</sec>
<sec id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Protein Expression and Purification</title>
<p>The gene encoding wild-type Int8 (residues 341&#x2013;419 of herstatin) (<xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>) was constructed by overlap-extension PCR. To improve solubility, the N-terminus of Int8 was tagged with a 5 &#xd7; Lys-tag using a Gly-Ser-Ser-Gly linker (MGKKKKKGSSG) (<xref ref-type="bibr" rid="B35">Kato et al., 2007</xref>). Additionally, a 6 &#xd7; His-tag was linked to the C-terminus using a Ser-Ser-Gly linker (SSGHHHHHH) to facilitate protein purification. Codons were optimized for high-level expression in <italic>Escherichia coli</italic> using the DNAWorks server (<xref ref-type="bibr" rid="B24">Hoover and Lubkowski, 2002</xref>). The Int8 DNA fragment was ligated into the <italic>Nco</italic>I/<italic>Bam</italic>HI sites of the pET-15b vector (MilliporeSigma, Burlington, MA, United States). The R371I mutation was introduced according to the method of the QuikChange site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, United States). The expression levels and solubilities of the wild-type and mutant Int8 proteins were predicted using the ESPRESSO server (<xref ref-type="bibr" rid="B23">Hirose and Noguchi, 2013</xref>).</p>
<p>Unlabeled and <sup>15</sup>N-labeled Int8, as well as the unlabeled R371I mutant of Int8 were expressed in <italic>E. coli</italic> BL21(DE3) cells (Nippon Gene, Tokyo, Japan) in 2&#xd7;YT medium (for unlabeled protein) or M9 minimal medium (for <sup>15</sup>N-labeled protein) containing ampicillin (50&#xa0;&#x3bc;g/ml). The cells were incubated at 37&#xb0;C and overexpression of Int8 was induced by addition of 1&#xa0;mM isopropyl &#x3b2;-D-1-thiogalactopyranoside at an optical density of 0.8 at 600&#xa0;nm. After incubation for an additional 5&#xa0;h, cells were collected, resuspended in denaturation buffer containing 20&#xa0;mM Tris-HCl (pH 8.0), 6&#xa0;M guanidine hydrochloride (GdnHCl), and 20&#xa0;mM imidazole, and sonicated on ice for 4&#xa0;min using a Branson Sonifier 250D Advanced (Branson, Danbury, CT, United States). The lysate was subsequently centrifuged at 35,140 &#xd7; g for 30&#xa0;min at 4&#xb0;C. The supernatant was filtered through a 0.45-&#xb5;m pore size membrane filter and applied to a column containing nickel-nitrilotriacetic acid agarose gel (Qiagen, Hilden, Germany). The column was washed with the denaturation buffer and wash buffer containing 20&#xa0;mM Tris-HCl (pH 8.0), 500&#xa0;mM NaCl, and 20&#xa0;mM imidazole. Int8 was eluted using elution buffer containing 20&#xa0;mM Tris-HCl (pH 8.0), 500&#xa0;mM NaCl, and 0.1&#x2013;1&#xa0;M imidazole. For CD and light scattering measurements, the eluate was further purified by size-exclusion chromatography using a Superdex 200&#xa0;pg column (Cytiva, Marlborough, MA, United States) with the buffer containing 10&#xa0;mM sodium phosphate (pH 6.0) and 50&#xa0;mM NaCl. For NMR and SAXS measurements, the eluate was desalted using a PD-10 column (Cytiva) in buffer containing 10&#xa0;mM sodium phosphate (pH 6.0) and 50&#xa0;mM NaCl. The purity of the Int8 proteins was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.</p>
<p>Protein concentrations were obtained using the following four methods: 1) absorption measurement at 280&#xa0;nm in the presence of 6&#xa0;M GdnHCl (<xref ref-type="bibr" rid="B16">Edelhoch, 1967</xref>; <xref ref-type="bibr" rid="B17">Gill and von Hippel, 1989</xref>), 2) absorption measurement at 280&#xa0;nm under native conditions (<xref ref-type="bibr" rid="B53">Pace et al., 1995</xref>), 3) absorption measurement at 205&#xa0;nm (<xref ref-type="bibr" rid="B1">Anthis and Clore, 2013</xref>), and 4) the Pierce BCA protein assay kit (Thermo Fisher Scientific, Waltham, MA, United States). Similar protein concentrations were obtained by all methods.</p>
</sec>
<sec id="s2-2">
<title>2.2 Circular Dichroism Measurements</title>
<p>Far-UV CD spectra were obtained from a J-805 spectropolarimeter (Jasco, Tokyo, Japan) at 200&#x2013;250&#xa0;nm using a quartz cuvette of 1&#xa0;mm path length at 25&#xb0;C. The temperature was controlled using a thermostat-circulating water bath. The protein concentrations of the wild type and R371I mutant of Int8 were 30 and 31&#xa0;&#x3bc;M, respectively. The samples additionally contained 10&#xa0;mM sodium phosphate (pH 6.0) and 50&#xa0;mM NaCl, in the presence or absence of 4&#xa0;M GdnHCl. Mean residue ellipticity (MRE) was calculated as previously described (<xref ref-type="bibr" rid="B2">Arai and Iwakura, 2005</xref>). The spectra in the presence of GdnHCl were measured at 211&#x2013;250&#xa0;nm. The helix content (<italic>f</italic>
<sub>H</sub>) was estimated from the MRE at 222&#xa0;nm according to the following equation (<xref ref-type="bibr" rid="B12">Chen et al., 1972</xref>):<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:msub>
<mml:mi mathvariant="italic">f</mml:mi>
<mml:mi mathvariant="normal">H</mml:mi>
</mml:msub>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mtext>&#xa0;</mml:mtext>
<mml:mo>-</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">MR</mml:mi>
<mml:msub>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mrow>
<mml:mi mathvariant="normal">222nm</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi mathvariant="normal">2340</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#xd7;</mml:mtext>
<mml:mrow>
<mml:mrow>
<mml:mi mathvariant="normal">100</mml:mi>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">30300</mml:mi>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
</p>
</sec>
<sec id="s2-3">
<title>2.3 Nuclear Magnetic Resonance Measurements</title>
<p>One-dimensional (1D) pulsed-field gradient (PFG) NMR spectra and two-dimensional (2D) <sup>1</sup>H-<sup>15</sup>N heteronuclear single quantum coherence spectra were recorded using a Bruker Avance500 spectrometer in a buffer containing 10&#xa0;mM sodium phosphate (pH 6.0), 50&#xa0;mM NaCl, 10% D<sub>2</sub>O, and 0.2&#xa0;mM sodium 3-(trimethylsilyl)-1-propanesulfonate (DSS) at 25&#xb0;C. All spectra were analyzed using NMRPipe (<xref ref-type="bibr" rid="B14">Delaglio et al., 1995</xref>) and NMRViewJ softwares (<xref ref-type="bibr" rid="B31">Johnson and Blevins, 1994</xref>). The protein concentrations of the wild-type and R371I mutant of Int8 were 350 and 150&#xa0;&#x3bc;M, respectively.</p>
<p>PFG NMR measurements were performed using a bipolar longitudinal eddy-current-decay pulse sequence (<xref ref-type="bibr" rid="B72">Wu et al., 1995</xref>; <xref ref-type="bibr" rid="B49">Nakamura et al., 2013</xref>; <xref ref-type="bibr" rid="B40">Kunihara et al., 2019</xref>). The samples contained 0.05% dioxane as a standard for molecular size analysis. The diffusion delay was 100&#xa0;ms, the gradient pulse width was 6&#xa0;ms, and the pulse separation was 0.6&#xa0;ms. The spectral center was 4.701&#xa0;ppm, and the spectral width was 8012.820&#xa0;Hz. Five spectra for the peak decay of dioxane and 15 spectra for Int8 were acquired while changing the strength of the diffusion gradient (<italic>g</italic>) from 5.35&#xa0;G/cm (5%) to 53.5&#xa0;G/cm (100%). The peak intensity (<italic>s</italic>) is related to <italic>g</italic> as follows:<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mfrac>
<mml:mi>s</mml:mi>
<mml:mrow>
<mml:msub>
<mml:mi>s</mml:mi>
<mml:mn>0</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mi mathvariant="normal">exp</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>d</mml:mi>
<mml:mo>&#x22C5;</mml:mo>
<mml:msup>
<mml:mi>g</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>where <italic>s</italic>
<sub>0</sub> is the peak intensity at 0% field gradient and <italic>d</italic> is the observed decay rate, which is proportional to the diffusion coefficient of the solute. The signal decay was fitted using <xref ref-type="disp-formula" rid="e2">Eq. 2</xref>, and the hydrodynamic radius, <italic>R</italic>
<sub>h</sub> of Int8 was calculated using the <italic>d</italic> value, as follows:<disp-formula id="e3">
<mml:math id="m3">
<mml:mrow>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">Int</mml:mi>
<mml:mn>8</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">dioxane</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">Int</mml:mi>
<mml:mn>8</mml:mn>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mi mathvariant="normal">h</mml:mi>
</mml:msub>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi mathvariant="normal">dioxane</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>where the <italic>R</italic>
<sub>h</sub> of dioxane is 2.12&#xa0;&#xc5; (<xref ref-type="bibr" rid="B71">Wilkins et al., 1999</xref>).</p>
</sec>
<sec id="s2-4">
<title>2.4 Small-Angle X-Ray Scattering Measurements</title>
<p>SAXS measurements were conducted at beamline (BL)-10C at the Photon Factory of the High Energy Accelerator Research Organization (KEK), Tsukuba, Japan. The camera length (1,996&#xa0;mm) was calibrated by the diffraction of silver behenate using FIT2D software (<xref ref-type="bibr" rid="B20">Hammersley, 1997</xref>). Samples were loaded into a mica-windowed cuvette with a 1&#xa0;mm path length and were irradiated by a monochromatic X-ray beam (1.488&#xa0;&#xc5;). Int8 concentration was 4.1&#xa0;mg/ml (390&#xa0;&#x3bc;M), and sample was centrifuged for 30&#xa0;min at 4&#xb0;C before measurement. The temperature in the cuvette was maintained at 25&#xb0;C using a circulating water bath. Scattering images were acquired by a PILATUS3 300&#xa0;KW detector (DECTRIS Ltd., Baden, Switzerland) at 10 &#xd7; 1&#xa0;s exposures. The scattering intensity, <italic>I</italic>(<italic>Q</italic>), was collected from 0.005 to 0.27&#xa0;&#xc5;<sup>&#x2212;1</sup>, where <italic>Q</italic> &#x3d; 4&#x3c0; sin (<italic>&#x3b8;</italic>/<italic>&#x3bb;</italic>) (<italic>&#x3bb;</italic>, wavelength; 2<italic>&#x3b8;</italic>, scattering angle). Scattering of blanks (buffer alone) was measured before and/or after measurement of protein samples. Circular averaging of 2D scattering data was performed using FIT2D. Blanks were subtracted from protein solution scattering data to obtain the scattering profile of protein molecules. The subtracted scattering data were binned per four data points to increase the signal-to-noise ratio. A radius of gyration, <italic>R</italic>
<sub>g</sub>, was obtained based on the Guinier approximation within the Guinier region (<italic>R</italic>
<sub>g</sub>
<italic>Q</italic> &#x3c; 1.3) (<xref ref-type="bibr" rid="B64">Trewhella et al., 2017</xref>):<disp-formula id="e4">
<mml:math id="m4">
<mml:mrow>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>I</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>Q</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>I</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mn>0</mml:mn>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msubsup>
<mml:mi>R</mml:mi>
<mml:mtext>g</mml:mtext>
<mml:mn>2</mml:mn>
</mml:msubsup>
</mml:mrow>
<mml:mn>3</mml:mn>
</mml:mfrac>
<mml:msup>
<mml:mi>Q</mml:mi>
<mml:mn>2</mml:mn>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(4)</label>
</disp-formula>where <italic>I</italic>(0) denotes the zero-angle scattering intensity (<xref ref-type="bibr" rid="B18">Glatter and Kratky, 1982</xref>; <xref ref-type="bibr" rid="B3">Arai et al., 2007</xref>). An <italic>R</italic>
<sub>g</sub> was also estimated using the approximation of the Debye function for a random coil within the range of (<italic>R</italic>
<sub>g</sub>
<italic>Q</italic>)<sup>2</sup> &#x3c; 3:<disp-formula id="e5">
<mml:math id="m5">
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>Q</mml:mi>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mi>a</mml:mi>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.359</mml:mn>
<mml:msup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mi>Q</mml:mi>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mtext>g</mml:mtext>
</mml:msub>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mn>2.206</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(5)</label>
</disp-formula>where <italic>a</italic> is the <italic>y</italic>-intercept of the <italic>I</italic>(<italic>Q</italic>)<sup>&#x2212;1</sup> versus <italic>Q</italic>
<sup>2.206</sup> plot (<xref ref-type="bibr" rid="B8">Calmettes et al., 1994</xref>). The pair-distance distribution function, <italic>P</italic>(<italic>r</italic>), was calculated using GNOM software (<xref ref-type="bibr" rid="B61">Svergun, 1992</xref>).</p>
<p>The SAXS data were further analyzed using the ensemble optimization method (EOM) 2.1 (<xref ref-type="bibr" rid="B6">Bernado et al., 2007</xref>; <xref ref-type="bibr" rid="B65">Tria et al., 2015</xref>; <xref ref-type="bibr" rid="B70">Vallet et al., 2018</xref>). In this analysis, a pool of 10,000 random conformations based on the Int8 amino acid sequence was first generated. Then, a genetic algorithm was run 100 times to select for an ensemble of conformations that best reproduces the experimental scattering curve.</p>
</sec>
<sec id="s2-5">
<title>2.5 Size-Exclusion Chromatography and Light Scattering Measurements</title>
<p>Size-exclusion chromatography (SEC) measurements were performed using a high-performance liquid chromatography (HPLC) system (LP-20AP, Shimadzu, Kyoto, Japan) and a Superdex 200 increase 3.2/300 column (Cytiva). The column was pre-equilibrated with 10&#xa0;mM sodium phosphate (pH 6.0) and 150&#xa0;mM NaCl, and samples of the wild-type and R371I mutant of Int8 were injected onto the column. The protein concentrations were 129 and 515&#xa0;&#x3bc;M for the wild type and 138 and 550&#xa0;&#x3bc;M for the R371I mutant. Molecular weight of the sample was determined on the HPLC system coupled to a Viscotek TDA 305 light scattering detector (Malvern Panalytical, Malvern, United Kingdom) as described previously (<xref ref-type="bibr" rid="B11">Chang et al., 2020</xref>). Bovine serum albumin (66.7&#xa0;kDa) was used as a standard for instrument calibration. Data analysis for estimating molecular weights was performed using OmniSEC software (Malvern Panalytical). The error in molecular weight was calculated from duplicate or triplicate measurements.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Characterization of Int8 Structure</title>
<p>The isolated Int8 domain containing a C-terminal 6 &#xd7; His-tag and an N-terminal 5 &#xd7; Lys-tag was overexpressed and purified from <italic>E. coli</italic>, to characterize its structure (<xref ref-type="sec" rid="s2">Section 2</xref>). The structure of Int8 under native conditions was measured by CD, NMR, and SAXS. The far-UV CD spectrum of Int8 under native conditions had small intensities at &#x223c;222&#xa0;nm but had a minimum at &#x223c;200&#xa0;nm, indicating a largely disordered structure (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The CD intensity at &#x223c;222&#xa0;nm was reduced to almost zero after protein unfolding by the addition of 4&#xa0;M GdnHCl (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The difference spectrum obtained by subtracting the CD spectrum in the presence of 4&#xa0;M GdnHCl from that measured under native conditions showed a minimum at 222&#xa0;nm, indicating the presence of an &#x3b1;-helical structure (<xref ref-type="fig" rid="F2">Figure 2B</xref>). These findings suggest that Int8 is largely disordered under native conditions, but retains a residual helical structure. The helix content as estimated from the CD intensity at 222&#xa0;nm is &#x223c;4% (<xref ref-type="disp-formula" rid="e1">Eq. 1</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>CD measurements. <bold>(A)</bold> Far-UV CD spectra of the wild type (red) and R371I mutant (blue) of Int8 in the absence (continuous lines) and presence (broken lines) of 4&#xa0;M GdnHCl. The MRE values are shown. The spectra in the presence of 4&#xa0;M GdnHCl were measured up to 211&#xa0;nm due to large absorption by GdnHCl at lower wavelengths. <bold>(B)</bold> Difference CD spectra calculated by subtracting the CD spectrum in the presence of 4&#xa0;M GdnHCl from that measured in the absence of GdnHCl.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g002.tif"/>
</fig>
<p>1D and 2D NMR spectra of Int8 showed that chemical shifts of amide protons were confined in a narrow range of 7.7&#x2013;8.7&#xa0;ppm (<xref ref-type="fig" rid="F3">Figures 3A,E</xref>). This indicates that the amide protons of Int8 are in similar environments, suggesting that Int8 is predominantly in a disordered state. PFG NMR measurements were performed to characterize the hydrodynamic radius, <italic>R</italic>
<sub>h</sub>. From the 1D NMR spectra of Int8, four peaks were selected at &#x223c;1&#x2013;2&#xa0;ppm (<xref ref-type="fig" rid="F3">Figure 3A</xref>) and peak intensities were plotted depending on the external magnetic field gradient, <italic>g</italic> (<xref ref-type="fig" rid="F3">Figure 3B</xref>). By fitting the decay curves (<xref ref-type="disp-formula" rid="e2">Eq. 2</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>), a parameter <italic>d</italic> was estimated, which is proportional to the diffusion coefficient. The <italic>d</italic> values were found to be almost identical for the four selected peaks. Using the Einstein-Stokes equation and the <italic>d</italic> value of the standard substance dioxane (<italic>R</italic>
<sub>h</sub> &#x3d; 2.12&#xa0;&#xc5;), which was included in the NMR sample, an <italic>R</italic>
<sub>h</sub> of 33 &#xb1; 2&#xa0;&#xc5; for Int8 was obtained (<xref ref-type="disp-formula" rid="e3">Eq. 3</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>NMR measurements. <bold>(A,C)</bold> One-dimensional NMR spectra of the wild type <bold>(A)</bold> and R371I mutant <bold>(C)</bold> of Int8. Arrows show the peaks used for the analysis of pulsed-field gradient (PFG) NMR measurement. The DSS peak is at 0&#xa0;ppm. <bold>(B,D)</bold> Peak intensity decay curves obtained by the PFG NMR measurement of the wild type <bold>(B)</bold> and R371I mutant <bold>(D)</bold>. <bold>(E)</bold> Two-dimensional <sup>1</sup>H<sup>&#x2212;15</sup>N heteronuclear single quantum coherence spectrum of the wild-type Int8.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g003.tif"/>
</fig>
<p>SAXS measurements were performed to characterize the molecular size and shape of Int8 (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Scattering intensities, <italic>I</italic>(<italic>Q</italic>), at scattering vectors, <italic>Q</italic> (&#xc5;<sup>&#x2212;1</sup>), were analyzed by a Kratky plot [<italic>I</italic>(<italic>Q</italic>)<italic>Q</italic>
<sup>2</sup> versus <italic>Q</italic> plot] which provides information on the molecular shape of a protein (<xref ref-type="bibr" rid="B18">Glatter and Kratky, 1982</xref>; <xref ref-type="bibr" rid="B3">Arai et al., 2007</xref>). The presence of a peak in the plot indicates that the protein has a compact, globular shape, whereas the absence of a peak is indicative of a random coil-like disordered structure (<xref ref-type="bibr" rid="B3">Arai et al., 2007</xref>). The Kratky plot of Int8 lacked a peak and instead showed a plateau, indicating that Int8 has a random coil-like disordered structure under native conditions (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The pair-distance distribution function, <italic>P</italic>(<italic>r</italic>), calculated by Fourier transformation of <italic>I</italic>(<italic>Q</italic>), showed a peak at &#x223c;20&#xa0;&#xc5;, but the maximum distance, <italic>D</italic>
<sub>max</sub>, between two atoms in Int8 was &#x223c;80&#xa0;&#xc5; (<xref ref-type="fig" rid="F4">Figure 4C</xref>). It is known that compact globular particles have a symmetric bell-shaped <italic>P</italic>(<italic>r</italic>), whereas unfolded particles have an extended tail in the <italic>P</italic>(<italic>r</italic>) function (<xref ref-type="bibr" rid="B36">Kikhney and Svergun, 2015</xref>). Thus, the <italic>P</italic>(<italic>r</italic>) of Int8 suggests an extended structure.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>SAXS analysis of wild-type Int8. <bold>(A)</bold> The ln <italic>I</italic>(<italic>Q</italic>) versus <italic>Q</italic> plot. The continuous line was obtained by the EOM fit. The intensity is shown in an arbitrary unit. <bold>(B)</bold> Kratky plot. <bold>(C)</bold> A pair-distance distribution function, <italic>P</italic>(<italic>r</italic>). <bold>(D)</bold> Guinier plot. The continuous line was obtained by Guinier approximation. <bold>(E)</bold> The <italic>I</italic>(<italic>Q</italic>)<sup>&#x2212;1</sup> versus <italic>Q</italic>
<sup>2.206</sup> plot. The continuous line was obtained by fitting to the Debye function for a random coil. <bold>(F)</bold> Scaling relationship for the native (green), intermediate (blue), and unfolded state (purple). The red circle shows the <italic>R</italic>
<sub>g</sub> of Int8 obtained by fitting to the Debye function.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g004.tif"/>
</fig>
<p>Next, the SAXS data were analyzed by generating a Guinier plot (i.e., ln <italic>I</italic>(<italic>Q</italic>) versus <italic>Q</italic>
<sup>2</sup> plot), which provides information on the molecular size of a protein, that is, the radius of gyration <italic>R</italic>
<sub>g</sub>, using the Guinier approximation (<xref ref-type="disp-formula" rid="e4">Eq. 4</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>). The <italic>R</italic>
<sub>g</sub> of Int8 was estimated to be 26.2 &#xb1; 0.5&#xa0;&#xc5; (<xref ref-type="fig" rid="F4">Figure 4D</xref>). Furthermore, the <italic>R</italic>
<sub>g</sub> estimated using the Debye function for a random coil was 29.9 &#xb1; 0.5&#xa0;&#xc5; (<xref ref-type="fig" rid="F4">Figure 4E</xref>; <xref ref-type="disp-formula" rid="e5">Eq. 5</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>). Since the Debye function is applicable to the scattering data at wider angles (<italic>R</italic>
<sub>g</sub>
<italic>Q</italic> &#x3c; 1.73) than the Guinier approximation (<italic>R</italic>
<sub>g</sub>
<italic>Q</italic> &#x3c; 1.3), the <italic>R</italic>
<sub>g</sub> value obtained by the Debye function is less affected by interparticle interference effects (<xref ref-type="bibr" rid="B8">Calmettes et al., 1994</xref>). Therefore, we used an <italic>R</italic>
<sub>g</sub> of 29.9&#xa0;&#xc5; for Int8. The <italic>R</italic>
<sub>g</sub> values of typical native, intermediate (molten globule), and unfolded states of globular proteins are related to the number of residues, <italic>N</italic>, as <italic>R</italic>
<sub>g</sub> &#x3d; <italic>R</italic>
<sub>0</sub>
<italic>N</italic>
<sup>
<italic>&#x3bd;</italic>
</sup>, where <italic>R</italic>
<sub>0</sub> is the <italic>R</italic>
<sub>g</sub> of a single amino acid residue and <italic>&#x3bd;</italic> is the scaling exponent (<xref ref-type="bibr" rid="B71">Wilkins et al., 1999</xref>; <xref ref-type="bibr" rid="B37">Kohn et al., 2004</xref>; <xref ref-type="bibr" rid="B3">Arai et al., 2007</xref>). The <italic>R</italic>
<sub>0</sub> and <italic>&#x3bd;</italic> values are 3.68 &#xb1; 0.86&#xa0;&#xc5; and 0.29 &#xb1; 0.02 for the native state (<xref ref-type="bibr" rid="B71">Wilkins et al., 1999</xref>), 3.68 &#xb1; 0.45&#xa0;&#xc5; and 0.35 &#xb1; 0.09 for the molten globule-like folding intermediate (<xref ref-type="bibr" rid="B3">Arai et al., 2007</xref>), and 1.927 &#xb1; 0.271&#xa0;&#xc5; and 0.598 &#xb1; 0.028 for the fully unfolded state (<xref ref-type="bibr" rid="B37">Kohn et al., 2004</xref>), respectively. A comparison of these values showed that the <italic>R</italic>
<sub>g</sub> of Int8 is almost the same as that of the fully unfolded state (<xref ref-type="fig" rid="F4">Figure 4F</xref>).</p>
<p>The <italic>R</italic>
<sub>g</sub>/<italic>R</italic>
<sub>h</sub> ratio is known to depend on the molecular shape of proteins. For spherical molecules (either folded proteins or disordered proteins in compact conformations) the <italic>R</italic>
<sub>g</sub>/<italic>R</italic>
<sub>h</sub> ratio is <inline-formula id="inf1">
<mml:math id="m6">
<mml:mrow>
<mml:msqrt>
<mml:mrow>
<mml:mn>3</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>5</mml:mn>
</mml:mrow>
</mml:msqrt>
</mml:mrow>
</mml:math>
</inline-formula> &#x223c; 0.78, whereas for proteins in the random-coil-like conformations it is 1.2&#x2013;1.6 (<xref ref-type="bibr" rid="B51">Nygaard et al., 2017</xref>). The <italic>R</italic>
<sub>g</sub>/<italic>R</italic>
<sub>h</sub> ratio for Int8 was 29.9/33 &#x3d; 0.91, suggesting that Int8 does not have a spherical shape, consistent with the <italic>P</italic>(<italic>r</italic>) function, but is not in a fully random-coil-like state.</p>
<p>Then, the ensemble of Int8 conformations that best fitted to the SAXS data was modeled by EOM (<xref ref-type="bibr" rid="B6">Bernado et al., 2007</xref>; <xref ref-type="bibr" rid="B65">Tria et al., 2015</xref>; <xref ref-type="bibr" rid="B70">Vallet et al., 2018</xref>). The ensemble best fitted to the scattering curve (<xref ref-type="fig" rid="F4">Figure 4A</xref>; &#x3c7;<sup>2</sup> &#x3d; 1.799) contained five representative conformations of Int8 with an averaged <italic>R</italic>
<sub>g</sub> of 28.5&#xa0;&#xc5; and <italic>D</italic>
<sub>max</sub> of 79.2&#xa0;&#xc5;, which are consistent with the above analysis (<xref ref-type="fig" rid="F5">Figure 5</xref>). The distributions of <italic>R</italic>
<sub>g</sub> and <italic>D</italic>
<sub>max</sub> for Int8 were smaller than those for the completely random pool (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). Furthermore, <italic>R</italic>
<sub>flex</sub>, indicative of the flexibility of the conformational ensemble, was 71.7% for Int8, which was smaller than that for the random pool (86.2%). Thus, the SAXS data suggest that Int8 has a molecular size comparable to the fully unfolded state but is less flexible than random coils probably due to the presence of residual helical structure.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>EOM analysis of the SAXS data. <bold>(A,B)</bold> The distribution of <italic>R</italic>
<sub>g</sub> <bold>(A)</bold> and <italic>D</italic>
<sub>max</sub> <bold>(B)</bold> for the completely random pool (black) and the ensemble of Int8 conformations (red). <bold>(C)</bold> Five representative conformations of the wild-type Int8 involved in the ensemble that was best fitted to the scattering curve of Int8 (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The <italic>R</italic>
<sub>g</sub>, <italic>D</italic>
<sub>max</sub>, and fraction (%) of the conformations are shown at the bottom.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g005.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 Structure Prediction of Int8</title>
<p>Secondary structure prediction of Int8 using the PSIPRED server (<xref ref-type="bibr" rid="B7">Buchan and Jones, 2019</xref>) showed that most regions of Int8 were in a random coil-like structure (<xref ref-type="fig" rid="F6">Figure 6A</xref>). Only a small number of residues in the middle of Int8 were predicted to be organized into two &#x3b1;-helices [helix 1 (residues 366&#x2013;370) and helix 2 (residues 374&#x2013;381)] and one &#x3b2;-strand (residues 410&#x2013;413). The AGADIR server (<xref ref-type="bibr" rid="B48">Mu&#xf1;oz and Serrano, 1994</xref>; <xref ref-type="bibr" rid="B41">Lacroix et al., 1998</xref>) predicted that helical propensity was low for both helices, although helix 2 (residues 373&#x2013;382) had a higher helical propensity than helix 1 (residues 365&#x2013;369) (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>). These predictions are consistent with the CD measurements that showed the presence of only a small amount of helical structure in Int8.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Secondary structure and disorder predictions of wild-type Int8. <bold>(A)</bold> Secondary structure prediction by PSIPRED. Pred indicates the predicted secondary structure (H, &#x3b1;-helix; E, &#x3b2;-sheet; and C, coil). Conf shows the confidence level of the prediction. Regions predicted to form &#x3b1;-helices and &#x3b2;-sheets are shown by red and yellow boxes, respectively. <bold>(B)</bold> Disorder prediction by nine different prediction servers. Black thick line shows the average of the predictions. Regions with a score larger than 0.5 are predicted to be disordered.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g006.tif"/>
</fig>
<p>Disorder prediction was performed using nine prediction servers, namely SPOT-Disorder2 (<xref ref-type="bibr" rid="B21">Hanson et al., 2019</xref>), MFDp2 (<xref ref-type="bibr" rid="B45">Mizianty et al., 2013</xref>), MetaDisorderMD2 (<xref ref-type="bibr" rid="B39">Kozlowski and Bujnicki, 2012</xref>), DISOPRED (<xref ref-type="bibr" rid="B32">Jones and Cozzetto, 2015</xref>), PrDOS (<xref ref-type="bibr" rid="B28">Ishida and Kinoshita, 2007</xref>), IUPred2A (<xref ref-type="bibr" rid="B44">Meszaros et al., 2018</xref>), DisProt(VSL2B) (<xref ref-type="bibr" rid="B52">Obradovic et al., 2005</xref>), DisEMBL (<xref ref-type="bibr" rid="B42">Linding et al., 2003</xref>), and POODLE-I (<xref ref-type="bibr" rid="B57">Shimizu, 2014</xref>). Although the results obtained differed between individual prediction servers, many predicted that most regions of Int8, particularly in the N- and C-terminal regions were intrinsically disordered (<xref ref-type="fig" rid="F6">Figure 6B</xref>), which was consistent with the secondary structure predictions. The disordered nature of Int8 is probably due to the presence of many proline and serine residues between residues 346&#x2013;365 and 384&#x2013;406. Thus, theoretical predictions suggest that Int8 is intrinsically disordered with a residual helical structure, consistent with our experimental results (<xref ref-type="fig" rid="F2">Figures 2</xref>&#x2013;<xref ref-type="fig" rid="F5">5</xref>).</p>
</sec>
<sec id="s3-3">
<title>3.3 Structure of the R371I Mutant</title>
<p>The structure of the R371I mutant of Int8, which does not bind HER2 (<xref ref-type="bibr" rid="B55">Shamieh et al., 2004</xref>), was predicted by PSIPRED and the disorder prediction servers to be similar to that of the wild-type Int8 (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>). The AGADIR server also predicted that the helical propensity of the R371I mutant is almost the same as that of the wild-type Int8 (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>).</p>
<p>The R371I mutant of Int8 was overexpressed in <italic>E. coli</italic> and purified. The CD spectrum of the R371I mutant of Int8 was found to be similar to that of wild-type Int8 (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The helix content of the mutant was estimated to be &#x223c;5% (<xref ref-type="disp-formula" rid="e1">Eq. 1</xref> in <xref ref-type="sec" rid="s2">Section 2</xref>). The difference CD spectrum between those measured in the absence and presence of 4&#xa0;M GdnHCl had a negative peak at &#x223c;222&#xa0;nm in the R371I mutant (<xref ref-type="fig" rid="F2">Figure 2B</xref>). These results indicate that the mutation little affected the helix content of Int8, which is consistent with the theoretical predictions (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>).</p>
<p>The 1D NMR spectrum of the R371I mutant showed that peaks for amide protons are confined in a narrow range of 7.7&#x2013;8.7&#xa0;ppm (<xref ref-type="fig" rid="F3">Figure 3C</xref>), indicating disordered structures. The molecular size of the R371I mutant of Int8 was estimated by PFG NMR measurement. Three peaks at &#x223c;1&#x2013;2&#xa0;ppm in the 1D NMR spectra of the mutant were used for the analysis of peak intensity decays (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). The <italic>R</italic>
<sub>h</sub> for the R371I mutant was 72 &#xb1; 2&#xa0;&#xc5;. This value is more than two-fold larger than that of wild-type Int8, indicating the formation of soluble aggregates in the mutant. The aggregation was observed despite the use of a lower protein concentration for the R371I mutant (150&#xa0;&#x3bc;M) than for the wild-type Int8 (350&#xa0;&#x3bc;M). Therefore, these results indicate that the R371I mutant of Int8 is prone to aggregation.</p>
<p>To further investigate the aggregation propensity of the mutant in more detail, we performed SEC measurements for the wild type and R371I mutant of Int8 (<xref ref-type="fig" rid="F7">Figure 7</xref>). The elution profile of the wild type showed a single peak without aggregates at both low (&#x223c;100&#xa0;&#x3bc;M) and high protein concentrations (&#x223c;500&#xa0;&#x3bc;M). The molecular weights estimated by static right-angle light scattering were 12.6 (&#xb1;0.1)&#xa0;kDa and 13.2 (&#xb1;0.1)&#xa0;kDa for the low and high concentration samples of the wild-type Int8, respectively (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>), both of which are close to the value expected for an Int8 monomer (10.5&#xa0;kDa). In contrast, a large amount of aggregates were observed at a high concentration (&#x223c;500&#xa0;&#x3bc;M) of the R371I mutant (<xref ref-type="fig" rid="F7">Figure 7B</xref>) with a molecular weight of 20.3 (&#xb1;0.5)&#xa0;kDa at the elution peak (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). At a low protein concentration (&#x223c;100&#xa0;&#x3bc;M), the formation of aggregates was suppressed (<xref ref-type="fig" rid="F7">Figure 7A</xref>), and the molecular weight at the elution peak was of 11.3 (&#xb1;0.6)&#xa0;kDa, which is close to the value for an Int8 monomer (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). However, the mutant started to elute earlier than the wild type, indicating the presence of slight aggregates (<xref ref-type="fig" rid="F7">Figure 7A</xref>). The large <italic>R</italic>
<sub>h</sub> of the mutant determined by the PFG NMR measurements at 150&#xa0;&#x3bc;M may correspond to the molecular size of these aggregates. Taken together, these results clearly demonstrate that the R371I mutant of Int8 is prone to aggregation.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>SEC measurements. <bold>(A,B)</bold> Elution profiles of the wild type (red) and R371I mutant (blue) of Int8 measured at low (&#x223c;100&#xa0;&#x3bc;M) <bold>(A)</bold> and high (&#x223c;500&#xa0;&#x3bc;M) protein concentrations <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g007.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Structure Modeling of Int8</title>
<p>Three-dimensional structure prediction of the wild type and R371I mutant of Int8 was performed using the standalone version of AlphaFold2 (<xref ref-type="bibr" rid="B33">Jumper et al., 2021</xref>). The predicted structure of wild-type Int8 was largely disordered, but had two &#x3b1;-helices at residues 365&#x2013;370 and 374&#x2013;382 corresponding to helices 1 and 2, respectively (<xref ref-type="fig" rid="F8">Figures 8A,C</xref>). The predicted structure of the R371I mutant was similar to that of the wild type (<xref ref-type="fig" rid="F8">Figure 8B</xref>), except that helix 1 (residues 368&#x2013;370) was shorter (<xref ref-type="fig" rid="F8">Figure 8D</xref>), which may be consistent with the slightly reduced helical propensity predicted by AGADIR for the mutant (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Structure modeling of Int8. <bold>(A,B)</bold> Overall structures of the wild type <bold>(A)</bold> and R371I mutant <bold>(B)</bold> of Int8 predicted by AlphaFold2. <bold>(C,D)</bold> Expanded views of the helical regions of the wild type <bold>(C)</bold> and R371I mutant <bold>(D)</bold>. R371 and I371 are shown by red and blue balls, respectively. The Figures were drawn using the PyMOL Molecular Graphics System, Version 2.4.0 Schr&#xf6;dinger, LLC.</p>
</caption>
<graphic xlink:href="fmolb-09-862910-g008.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>4 Discussion</title>
<p>In this study, we characterized the structure of Int8, the intron 8-encoded domain of herstatin. Since Int8 binds and interferes with the homo- and hetero-dimerization of HER1, HER2, and HER4, it serves as an intrinsic inhibitor of the HER family proteins. Structure prediction and experimental characterization by CD, NMR, and SAXS indicated that Int8 is largely disordered, but retains a residual helical structure. Moreover, it had a molecular size similar to that of the fully unfolded state, although the conformational ensemble was less flexible than random coils. These results clearly indicate that Int8 is intrinsically disordered. To our knowledge, this is the first report of an IDR encoded by an intron. Further, the structure of the Int8 domain might be classified as a pre-molten globule state, which has an expanded overall structure but with unstable secondary structure (<xref ref-type="bibr" rid="B54">Ptitsyn, 1995</xref>; <xref ref-type="bibr" rid="B67">Uversky, 2002a</xref>; <xref ref-type="bibr" rid="B69">b</xref>; <xref ref-type="bibr" rid="B63">Tcherkasskaya et al., 2003</xref>). Pre-molten globule-like structures have also been reported for other intrinsically disordered proteins (IDPs) (<xref ref-type="bibr" rid="B54">Ptitsyn, 1995</xref>; <xref ref-type="bibr" rid="B67">Uversky, 2002a</xref>; <xref ref-type="bibr" rid="B69">b</xref>; <xref ref-type="bibr" rid="B63">Tcherkasskaya et al., 2003</xref>; <xref ref-type="bibr" rid="B40">Kunihara et al., 2019</xref>). Since Int8 is known to have tumor-suppressive activity (<xref ref-type="bibr" rid="B43">Lv et al., 2012</xref>), it is an interesting example of an intron-encoded IDR that may function as an antitumor drug.</p>
<p>Many IDPs exhibit coupled folding and binding behaviors, where binding is accompanied by folding (<xref ref-type="bibr" rid="B4">Arai, 2018</xref>). In many cases, the residues involved in coupled folding and binding have a propensity to form a helical structure (<xref ref-type="bibr" rid="B46">Mohan et al., 2006</xref>). Therefore, the residual helical structure present in Int8 may serve as the putative HER-binding site of Int8.</p>
<p>Previous reports have shown that intrinsic disorder is involved in protein-protein interactions mediated by HER proteins. The intracellular kinase domain of HER1 contains an IDR at the dimerization interface, which reorganizes into an ordered structure upon dimerization (<xref ref-type="bibr" rid="B56">Shan et al., 2012</xref>). Furthermore, HER1 dimerization is facilitated by cancer-related mutations that suppress local disorders at the dimerization interface (<xref ref-type="bibr" rid="B56">Shan et al., 2012</xref>). Therefore, intrinsic disorder regulates the dimerization of HER proteins. Thus, the use of intrinsic disorder in the interaction between herstatin and HER proteins is not exceptional. Rather, IDRs may play an important role in regulating protein-protein interactions related to cell proliferation (<xref ref-type="bibr" rid="B68">Uversky et al., 2008</xref>).</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>DT and MA designed the study and wrote the paper. DT, SS, and NS conducted protein expression and purification and CD measurements. DT, TK, YH, and MA conducted NMR experiment. DT, TK, HK, JI, YH, and MA conducted SAXS experiment. SS, NS, and YH conducted SEC and light scattering measurements. DT, KO, and MA conducted structure prediction. KO and MA conducted structure modeling. DT, SS, NS, KO, YH, and MA analyzed the data. All authors reviewed the results and approved the final version of the manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by JSPS KAKENHI Grant Numbers JP16H02217, JP19H02521, and JP21K18841 (YH and MA).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>SAXS measurement was performed under the approval of the Photon Factory Program Advisory Committee.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2022.862910/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2022.862910/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<sec id="s11">
<title>Abbreviations</title>
<p>1D, one-dimensional; 2D, two-dimensional; CD, circular dichroism; <italic>D</italic>
<sub>max</sub>, maximum distance; DSS, sodium 3-(trimethylsilyl)-1-propanesulfonate; ECD, extracellular domain; EOM, ensemble optimization method; GdnHCl, guanidine hydrochloride; HER, human epidermal growth factor receptor; HPLC, high-performance liquid chromatography; <italic>I</italic>(0), zero-angle scattering intensity; IDP, intrinsically disordered protein; IDR, intrinsically disordered region; <italic>I</italic>(<italic>Q</italic>), scattering intensity; NMR, nuclear magnetic resonance; PFG, pulsed-field gradient; <italic>P</italic>(<italic>r</italic>), pair-distance distribution function; <italic>Q</italic>, scattering vector; <italic>R</italic>
<sub>g</sub>, radius of gyration; <italic>R</italic>
<sub>h</sub>, hydrodynamic radius; SAXS, small-angle X-ray scattering; SEC, size-exclusion chromatography; UV, ultraviolet.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anthis</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Clore</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Sequence-Specific Determination of Protein and Peptide Concentrations by Absorbance at 205 nm</article-title>. <source>Protein Sci.</source> <volume>22</volume>, <fpage>851</fpage>&#x2013;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1002/pro.2253</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwakura</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Probing the Interactions between the Folding Elements Early in the Folding of <italic>Escherichia coli</italic> Dihydrofolate Reductase by Systematic Sequence Perturbation Analysis</article-title>. <source>J. Mol. Biol.</source> <volume>347</volume>, <fpage>337</fpage>&#x2013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2005.01.033</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondrashkina</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kayatekin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Iwakura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bilsel</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Microsecond Hydrophobic Collapse in the Folding of <italic>Escherichia coli</italic> Dihydrofolate Reductase, an &#x3b1;/&#x3b2;-Type Protein</article-title>. <source>J. Mol. Biol.</source> <volume>368</volume>, <fpage>219</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2007.01.085</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Unified Understanding of Folding and Binding Mechanisms of Globular and Intrinsically Disordered Proteins</article-title>. <source>Biophys. Rev.</source> <volume>10</volume>, <fpage>163</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1007/s12551-017-0346-7</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azios</surname>
<given-names>N. G.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Denton</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Expression of Herstatin, an Autoinhibitor of HER-2/Neu, Inhibits Transactivation of HER-3 by HER-2 and Blocks EGF Activation of the EGF Receptor</article-title>. <source>Oncogene</source> <volume>20</volume>, <fpage>5199</fpage>&#x2013;<lpage>5209</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1204555</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernad&#xf3;</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mylonas</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Petoukhov</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Blackledge</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Svergun</surname>
<given-names>D. I.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Structural Characterization of Flexible Proteins Using Small-Angle X-Ray Scattering</article-title>. <source>J. Am. Chem. Soc.</source> <volume>129</volume>, <fpage>5656</fpage>&#x2013;<lpage>5664</lpage>. <pub-id pub-id-type="doi">10.1021/ja069124n</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchan</surname>
<given-names>D. W. A.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>D. T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The PSIPRED Protein Analysis Workbench: 20 Years on</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume>, <fpage>W402</fpage>&#x2013;<lpage>W407</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz297</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calmettes</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Desmadril</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minard</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Receveur</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J. C.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>How Random Is a Highly Denatured Protein?</article-title> <source>Biophysical Chem.</source> <volume>53</volume>, <fpage>105</fpage>&#x2013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/0301-4622(94)00081-6</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camenisch</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Schroeder</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Klewer</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Heart-Valve Mesenchyme Formation Is Dependent on Hyaluronan-Augmented Activation of ErbB2-ErbB3 Receptors</article-title>. <source>Nat. Med.</source> <volume>8</volume>, <fpage>850</fpage>&#x2013;<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1038/nm742</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cha</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Structure-Based Design of Peptides against HER2 with Cytotoxicity on Colon Cancer</article-title>. <source>Artif. Cell Nanomedicine, Biotechnol.</source> <volume>45</volume>, <fpage>649</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.3109/21691401.2016.1167705</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimba</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Electrostatic Interactions at the Interface of Two Enzymes Are Essential for Two-step Alkane Biosynthesis in Cyanobacteria</article-title>. <source>Biosci. Biotechnol. Biochem.</source> <volume>84</volume>, <fpage>228</fpage>&#x2013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1080/09168451.2019.1677142</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>1972</year>). <article-title>Determination of the Secondary Structures of Proteins by Circular Dichroism and Optical Rotatory Dispersion</article-title>. <source>Biochemistry</source> <volume>11</volume>, <fpage>4120</fpage>&#x2013;<lpage>4131</lpage>. <pub-id pub-id-type="doi">10.1021/bi00772a015</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Citri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yarden</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>EGF-ERBB Signalling: Towards the Systems Level</article-title>. <source>Nat. Rev. Mol. Cel Biol.</source> <volume>7</volume>, <fpage>505</fpage>&#x2013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1962</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delaglio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Grzesiek</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vuister</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bax</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>NMRPipe: A Multidimensional Spectral Processing System Based on Unix Pipes</article-title>. <source>J. Biomol. NMR</source> <volume>6</volume>, <fpage>277</fpage>&#x2013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1007/BF00197809</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doherty</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Bond</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jardim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adelman</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>The HER-2/Neu Receptor Tyrosine Kinase Gene Encodes a Secreted Autoinhibitor</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>96</volume>, <fpage>10869</fpage>&#x2013;<lpage>10874</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.19.10869</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Edelhoch</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1967</year>). <article-title>Spectroscopic Determination of Tryptophan and Tyrosine in Proteins</article-title>. <source>Biochemistry</source> <volume>6</volume>, <fpage>1948</fpage>&#x2013;<lpage>1954</lpage>. <pub-id pub-id-type="doi">10.1021/bi00859a010</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>von Hippel</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Calculation of Protein Extinction Coefficients from Amino Acid Sequence Data</article-title>. <source>Anal. Biochem.</source> <volume>182</volume>, <fpage>319</fpage>&#x2013;<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/0003-2697(89)90602-7</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Glatter</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kratky</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>1982</year>). <source>Small Angle X-Ray Scattering</source>. <publisher-loc>London; New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>. </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gompels</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Malik</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Madden</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shepard</surname>
<given-names>H. M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Human Epidermal Growth Factor Receptor Bispecific Ligand Trap RB200: Abrogation of Collagen-Induced Arthritis in Combination with Tumour Necrosis Factor Blockade</article-title>. <source>Arthritis Res. Ther.</source> <volume>13</volume>, <fpage>R161</fpage>. <pub-id pub-id-type="doi">10.1186/ar3480</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammersley</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>FIT2D: An Introduction and Overview</article-title>. <comment>ESRF Internal Report, ESRF97HA02T</comment>. </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paliwal</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Litfin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>SPOT-Disorder2: Improved Protein Intrinsic Disorder Prediction by Ensembled Deep Learning</article-title>. <source>Genomics, Proteomics &#x26; Bioinformatics</source> <volume>17</volume>, <fpage>645</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.1016/j.gpb.2019.01.004</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gautrey</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kirby</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tyson-Capper</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>HER2 Splice Variants in Breast Cancer: Investigating Their Impact on Diagnosis and Treatment Outcomes</article-title>. <source>Oncotarget</source> <volume>11</volume>, <fpage>4338</fpage>&#x2013;<lpage>4357</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.27789</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>ESPRESSO: A System for Estimating Protein Expression and Solubility in Protein Expression Systems</article-title>. <source>Proteomics</source> <volume>13</volume>, <fpage>1444</fpage>&#x2013;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201200175</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoover</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Lubkowski</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>DNAWorks: An Automated Method for Designing Oligonucleotides for PCR-Based Gene Synthesis</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume>, <fpage>43e</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.10.e43</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howe</surname>
<given-names>L. R.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>P. H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer</article-title>. <source>Cancer Prev. Res.</source> <volume>4</volume>, <fpage>1149</fpage>&#x2013;<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-11-0334</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jing</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>
<italic>In Vivo</italic> Identification of the Interaction Site of ErbB2 Extracellular Domain with its Autoinhibitor</article-title>. <source>J. Cel. Physiol.</source> <volume>205</volume>, <fpage>335</fpage>&#x2013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.20409</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Sequestering ErbB2 in Endoplasmic Reticulum by its Autoinhibitor from Translocation to Cell Surface: An Autoinhibition Mechanism of ErbB2 Expression</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>342</volume>, <fpage>19</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.01.115</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>PrDOS: Prediction of Disordered Protein Regions from Amino Acid Sequence</article-title>. <source>Nucleic Acids Res.</source> <volume>35</volume>, <fpage>W460</fpage>&#x2013;<lpage>W464</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm363</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jackson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Browell</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gautrey</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tyson-Capper</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Clinical Significance of HER-2 Splice Variants in Breast Cancer Progression and Drug Resistance</article-title>. <source>Int. J. Cel Biol.</source> <volume>2013</volume>, <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1155/2013/973584</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jhabvala-Romero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Denton</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Herstatin Inhibits Heregulin-Mediated Breast Cancer Cell Growth and Overcomes Tamoxifen Resistance in Breast Cancer Cells that Overexpress Her-2</article-title>. <source>Oncogene</source> <volume>22</volume>, <fpage>8178</fpage>&#x2013;<lpage>8186</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206912</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Blevins</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>NMR View: A Computer Program for the Visualization and Analysis of NMR Data</article-title>. <source>J. Biomol. NMR</source> <volume>4</volume>, <fpage>603</fpage>&#x2013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1007/bf00404272</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Cozzetto</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>DISOPRED3: Precise Disordered Region Predictions with Annotated Protein-Binding Activity</article-title>. <source>Bioinformatics</source> <volume>31</volume>, <fpage>857</fpage>&#x2013;<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu744</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jumper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pritzel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Figurnov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ronneberger</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Highly Accurate Protein Structure Prediction with AlphaFold</article-title>. <source>Nature</source> <volume>596</volume>, <fpage>583</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Justman</surname>
<given-names>Q. A.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Herstatin, an Autoinhibitor of the Human Epidermal Growth Factor Receptor 2 Tyrosine Kinase, Modulates Epidermal Growth Factor Signaling Pathways Resulting in Growth Arrest</article-title>. <source>J. Biol. Chem.</source> <volume>277</volume>, <fpage>20618</fpage>&#x2013;<lpage>20624</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111359200</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ebina</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuwajima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Soda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Mutational Analysis of Protein Solubility Enhancement Using Short Peptide Tags</article-title>. <source>Biopolymers</source> <volume>85</volume>, <fpage>12</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/bip.20596</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kikhney</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Svergun</surname>
<given-names>D. I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A Practical Guide to Small Angle X-Ray Scattering (SAXS) of Flexible and Intrinsically Disordered Proteins</article-title>. <source>FEBS Lett.</source> <volume>589</volume>, <fpage>2570</fpage>&#x2013;<lpage>2577</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2015.08.027</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohn</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Millett</surname>
<given-names>I. S.</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zagrovic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dillon</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Cingel</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Random-Coil Behavior and the Dimensions of Chemically Unfolded Proteins</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>12491</fpage>&#x2013;<lpage>12496</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0403643101</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koletsa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kostopoulos</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Charalambous</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Christoforidou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nenopoulou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kotoula</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>A Splice Variant of HER2 Corresponding to Herstatin Is Expressed in the Noncancerous Breast and in Breast Carcinomas</article-title>. <source>Neoplasia</source> <volume>10</volume>, <fpage>687</fpage>&#x2013;<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1593/neo.08314</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozlowski</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Bujnicki</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>MetaDisorder: A Meta-Server for the Prediction of Intrinsic Disorder in Proteins</article-title>. <source>BMC Bioinformatics</source> <volume>13</volume>, <fpage>111</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-13-111</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kunihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Conformational Diversity in the Intrinsically Disordered HIV-1 Tat Protein Induced by Zinc and pH</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>509</volume>, <fpage>564</fpage>&#x2013;<lpage>569</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.12.126</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacroix</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Viguera</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Elucidating the Folding Problem of &#x3b1;-Helices: Local Motifs, Long-Range Electrostatics, Ionic-Strength Dependence and Prediction of NMR Parameters</article-title>. <source>J. Mol. Biol.</source> <volume>284</volume>, <fpage>173</fpage>&#x2013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1998.2145</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linding</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Diella</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Protein Disorder Prediction</article-title>. <source>Structure</source> <volume>11</volume>, <fpage>1453</fpage>&#x2013;<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2003.10.002</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>The Peptide Derived from ErbB2 Auto-Inhibitor Herstatin Shared in the Same Epitope and Function with Functional Antibody 2C4</article-title>. <source>Mol. Biotechnol.</source> <volume>51</volume>, <fpage>174</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/s12033-011-9454-y</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe9;sz&#xe1;ros</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Erd&#x151;s</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Doszt&#xe1;nyi</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>IUPred2A: Context-dependent Prediction of Protein Disorder as a Function of Redox State and Protein Binding</article-title>. <source>Nucleic Acids Res.</source> <volume>46</volume>, <fpage>W329</fpage>&#x2013;<lpage>W337</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky384</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizianty</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kurgan</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>MFDp2</article-title>. <source>Intrinsically Disordered Proteins</source> <volume>1</volume>, <fpage>e24428</fpage>. <pub-id pub-id-type="doi">10.4161/idp.24428</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Oldfield</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Radivojac</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vacic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cortese</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Dunker</surname>
<given-names>A. K.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Analysis of Molecular Recognition Features (MoRFs)</article-title>. <source>J. Mol. Biol.</source> <volume>362</volume>, <fpage>1043</fpage>&#x2013;<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2006.07.087</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mujoo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>B.-K.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Regulation of ERBB3/HER3 Signaling in Cancer</article-title>. <source>Oncotarget</source> <volume>5</volume>, <fpage>10222</fpage>&#x2013;<lpage>10236</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.2655</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mu&#xf1;oz</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Elucidating the Folding Problem of Helical Peptides Using Empirical Parameters</article-title>. <source>Nat. Struct. Mol. Biol.</source> <volume>1</volume>, <fpage>399</fpage>&#x2013;<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1038/nsb0694-399</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Aizawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kariya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Demura</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Molecular Mechanisms of the Cytotoxicity of Human &#x3b1;-Lactalbumin Made Lethal to Tumor Cells (HAMLET) and Other Protein-Oleic Acid Complexes</article-title>. <source>J. Biol. Chem.</source> <volume>288</volume>, <fpage>14408</fpage>&#x2013;<lpage>14416</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.437889</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Normanno</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Maiello</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>De Luca</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs): Simple Drugs with a Complex Mechanism of Action?</article-title> <source>J. Cel. Physiol.</source> <volume>194</volume>, <fpage>13</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.10194</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nygaard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kragelund</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Papaleo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lindorff-Larsen</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>An Efficient Method for Estimating the Hydrodynamic Radius of Disordered Protein Conformations</article-title>. <source>Biophysical J.</source> <volume>113</volume>, <fpage>550</fpage>&#x2013;<lpage>557</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2017.06.042</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obradovic</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vucetic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Radivojac</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dunker</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Exploiting Heterogeneous Sequence Properties Improves Prediction of Protein Disorder</article-title>. <source>Proteins</source> <volume>61</volume> (<issue>Suppl. 7</issue>), <fpage>176</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1002/prot.20735</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pace</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Vajdos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fee</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Grimsley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gray</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>How to Measure and Predict the Molar Absorption Coefficient of a Protein</article-title>. <source>Protein Sci.</source> <volume>4</volume>, <fpage>2411</fpage>&#x2013;<lpage>2423</lpage>. <pub-id pub-id-type="doi">10.1002/pro.5560041120</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ptitsyn</surname>
<given-names>O. B.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Molten Globule and Protein Folding</article-title>. <source>Adv. Protein Chem.</source> <volume>47</volume>, <fpage>83</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/s0065-3233(08)60546-x</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shamieh</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Denton</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Receptor Binding Specificities of Herstatin and its Intron 8-Encoded Domain</article-title>. <source>FEBS Lett.</source> <volume>568</volume>, <fpage>163</fpage>&#x2013;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2004.05.027</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Eastwood</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Arkhipov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dror</surname>
<given-names>R. O.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization</article-title>. <source>Cell</source> <volume>149</volume>, <fpage>860</fpage>&#x2013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2012.02.063</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Shimizu</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2014</year>). &#x201c;<article-title>POODLE: Tools Predicting Intrinsically Disordered Regions of Amino Acid Sequence</article-title>,&#x201d; in <source>Protein Structure Prediction</source>. Editor <person-group person-group-type="editor">
<name>
<surname>Kihara</surname>
<given-names>D.</given-names>
</name>
</person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer New York</publisher-name>), <fpage>131</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-0366-5_10</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silipo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gautrey</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Satam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lennard</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tyson-Capper</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>How Is Herstatin, a Tumor Suppressor Splice Variant of the Oncogene HER2, Regulated?</article-title> <source>RNA Biol.</source> <volume>14</volume>, <fpage>536</fpage>&#x2013;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1080/15476286.2016.1267074</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staverosky</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Muldoon</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Neuwelt</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Clinton</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Herstatin, an Autoinhibitor of the Epidermal Growth Factor Receptor Family, Blocks the Intracranial Growth of Glioblastoma</article-title>. <source>Clin. Cancer Res.</source> <volume>11</volume>, <fpage>335</fpage>&#x2013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.335.11.1</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stix</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Blockbuster Dreams</article-title>. <source>Sci. Am.</source> <volume>294</volume>, <fpage>60</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/scientificamerican0506-60</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Svergun</surname>
<given-names>D. I.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Determination of the Regularization Parameter in Indirect-Transform Methods Using Perceptual Criteria</article-title>. <source>J. Appl. Cryst.</source> <volume>25</volume>, <fpage>495</fpage>&#x2013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1107/S0021889892001663</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mahato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The Role of HER2 in Cancer Therapy and Targeted Drug Delivery</article-title>. <source>J. Controlled Release</source> <volume>146</volume>, <fpage>264</fpage>&#x2013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2010.04.009</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tcherkasskaya</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Biophysical Constraints for Protein Structure Prediction</article-title>. <source>J. Proteome Res.</source> <volume>2</volume>, <fpage>37</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1021/pr025552q</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trewhella</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Duff</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gabel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guss</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Hendrickson</surname>
<given-names>W. A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>2017 Publication Guidelines for Structural Modelling of Small-Angle Scattering Data from Biomolecules in Solution: An Update</article-title>. <source>Acta Cryst. Sect D Struct. Biol.</source> <volume>73</volume>, <fpage>710</fpage>&#x2013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1107/S2059798317011597</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tria</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>H. D. T.</given-names>
</name>
<name>
<surname>Kachala</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Svergun</surname>
<given-names>D. I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Advanced Ensemble Modelling of Flexible Macromolecules Using X-Ray Solution Scattering</article-title>. <source>Int. Union Crystallogr. J.</source> <volume>2</volume>, <fpage>207</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1107/S205225251500202X</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<collab>UniProt Consortium</collab> (<year>2021</year>). <article-title>UniProt: The Universal Protein Knowledgebase in 2021</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume>, <fpage>D480</fpage>&#x2013;<lpage>D489</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa1100</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
</person-group> (<year>2002a</year>). <article-title>Natively Unfolded Proteins: A Point where Biology Waits for Physics</article-title>. <source>Protein Sci.</source> <volume>11</volume>, <fpage>739</fpage>&#x2013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1110/ps.4210102</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Oldfield</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Dunker</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Intrinsically Disordered Proteins in Human Diseases: Introducing the D<sup>2</sup> Concept</article-title>. <source>Annu. Rev. Biophys.</source> <volume>37</volume>, <fpage>215</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biophys.37.032807.125924</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
</person-group> (<year>2002b</year>). <article-title>What Does it Mean to Be Natively Unfolded?</article-title> <source>Eur. J. Biochem.</source> <volume>269</volume>, <fpage>2</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1046/j.0014-2956.2001.02649.x</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallet</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Miele</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Uciechowska-Kaczmarzyk</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Liwo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Duclos</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Samsonov</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Insights into the Structure and Dynamics of Lysyl Oxidase Propeptide, a Flexible Protein with Numerous Partners</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>11768</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-30190-6</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkins</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Grimshaw</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Receveur</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Hydrodynamic Radii of Native and Denatured Proteins Measured by Pulse Field Gradient NMR Techniques</article-title>. <source>Biochemistry</source> <volume>38</volume>, <fpage>16424</fpage>&#x2013;<lpage>16431</lpage>. <pub-id pub-id-type="doi">10.1021/bi991765q</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>An Improved Diffusion-Ordered Spectroscopy Experiment Incorporating Bipolar-Gradient Pulses</article-title>. <source>J. Magn. Reson. Ser. A</source> <volume>115</volume>, <fpage>260</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1006/jmra.1995.1176</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yarden</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pines</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The ERBB Network: At Last, Cancer Therapy Meets Systems Biology</article-title>. <source>Nat. Rev. Cancer</source> <volume>12</volume>, <fpage>553</fpage>&#x2013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3309</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>